1MV4

TM9A251-284: A Peptide Model of the C-Terminus of a Rat Striated Alpha Tropomyosin

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_13C-separated_NOESY	1-2 MM	100 MM NACL, 20 MM POTASSIUM PHOSPHATE, 10% DUETERIUM OXIDE, 90% H20, PH 6.4	0.12 N	6.40	1 atm	283.00
2	3D_15N-separated_NOESY	1-2 MM	100 MM NACL, 20 MM POTASSIUM PHOSPHATE, 10% DUETERIUM OXIDE, 90% H20, PH 6.4	0.12 N	6.40	1 atm	283.00
3	3D_13C-X-FILTERED NOESY	1-2 MM	100 MM NACL, 20 MM POTASSIUM PHOSPHATE, 10% DUETERIUM OXIDE, 90% H20, PH 6.4	0.12 N	6.40	1 atm	283.00

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
1648 CONFORMATIONALLY- RESTRICTING NOE CONSTRAINTS (OUT OF A TOTAL OF 2036 NOE DERIVED DISTANCES) 52 LOOSE DIHEDRAL ANGLE CONSTRAINTS AND 48 BACKBONE INTRA- HELICAL HYDROGEN BOND CONSTRAINTS WERE UTILILIZED.	REFINEMENT DETAILS CAN BE FOUND IN REFERENCE CITED ABOVE	DYANA

NMR Ensemble Information
Conformer Selection Criteria	STRUCTURES WITH COVALENT GEOMETRY, STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (fewest violations)

Additional NMR Experimental Information
Details	THE RESONANCE ASSIGNMENTS WERE MADE USING THROUGH BOND TRIPLE RESONANCE EXPERIMENTS INCLUDING HN(CA)CO, HNCO, H(CA)(C0)NH, H(CA)NH, CA(CO)NH, CANH, CBCA(CO)NH, CBCANH, HCCH-COSY AND CCH-COSY

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	DYANA	1.5	GUNTERT, WUTHRICH
2	structure solution	VNMR	5.3B	VARIAN ASSOCIATES
3	structure solution	DYANA	1.5	GUNTERT, WUTHRICH
4	structure solution	AutoAssign	1.0	HUANG, MONTELIONE
5	structure solution	AutoStructure	1.0	HUANG, MONTELIONE
6	structure solution	Sparky	3.74	GODDARD, KNELLER

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.